Correlation Between Cumberland Pharmaceuticals and Bausch Lomb
Can any of the company-specific risk be diversified away by investing in both Cumberland Pharmaceuticals and Bausch Lomb at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cumberland Pharmaceuticals and Bausch Lomb into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cumberland Pharmaceuticals and Bausch Lomb Corp, you can compare the effects of market volatilities on Cumberland Pharmaceuticals and Bausch Lomb and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cumberland Pharmaceuticals with a short position of Bausch Lomb. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cumberland Pharmaceuticals and Bausch Lomb.
Diversification Opportunities for Cumberland Pharmaceuticals and Bausch Lomb
-0.03 | Correlation Coefficient |
Good diversification
The 3 months correlation between Cumberland and Bausch is -0.03. Overlapping area represents the amount of risk that can be diversified away by holding Cumberland Pharmaceuticals and Bausch Lomb Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bausch Lomb Corp and Cumberland Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cumberland Pharmaceuticals are associated (or correlated) with Bausch Lomb. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bausch Lomb Corp has no effect on the direction of Cumberland Pharmaceuticals i.e., Cumberland Pharmaceuticals and Bausch Lomb go up and down completely randomly.
Pair Corralation between Cumberland Pharmaceuticals and Bausch Lomb
Given the investment horizon of 90 days Cumberland Pharmaceuticals is expected to generate 2.7 times more return on investment than Bausch Lomb. However, Cumberland Pharmaceuticals is 2.7 times more volatile than Bausch Lomb Corp. It trades about 0.04 of its potential returns per unit of risk. Bausch Lomb Corp is currently generating about 0.0 per unit of risk. If you would invest 165.00 in Cumberland Pharmaceuticals on September 12, 2024 and sell it today you would earn a total of 74.50 from holding Cumberland Pharmaceuticals or generate 45.15% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cumberland Pharmaceuticals vs. Bausch Lomb Corp
Performance |
| Timeline |
| Cumberland Pharmaceuticals |
| Bausch Lomb Corp |
Cumberland Pharmaceuticals and Bausch Lomb Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cumberland Pharmaceuticals and Bausch Lomb
The main advantage of trading using opposite Cumberland Pharmaceuticals and Bausch Lomb positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cumberland Pharmaceuticals position performs unexpectedly, Bausch Lomb can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bausch Lomb will offset losses from the drop in Bausch Lomb's long position.The idea behind Cumberland Pharmaceuticals and Bausch Lomb Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Bausch Lomb vs. The Cooper Companies, | Bausch Lomb vs. ICU Medical | Bausch Lomb vs. Hologic | Bausch Lomb vs. Becton Dickinson and |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Complementary Tools
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Stocks Directory Find actively traded stocks across global markets | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |